Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Environment

Dupont, Ewg Spar over Pfoa Study

November 22, 2004 | A version of this story appeared in Volume 82, Issue 47

The Environmental Working Group is asking EPA to fine DuPont for failing to submit to the agency a study of perfluorooctanoic acid (PFOA) in the blood of people living near the firm's Parkersburg, W.Va., plant. PFOA is used in the manufacture of fluoropolymers including DuPont's Teflon. The study in question found an average of 67.6 ppb PFOA, which contrasts with the average 5.6 ppb found in the general U.S. population, EWG says. DuPont responds that the analysis was of PFOA in the blood of the 12 plaintiffs in a class-action lawsuit filed against the company and was undertaken at DuPont's request. DuPont says the levels of PFOA found in these people's blood are well below the 0.5 to 2 ppm typically found in workers exposed to the compound. No adverse health effects have been observed in workers exposed to PFOA, DuPont adds. EWG points out that the current level of PFOA in the blood of the general population has spurred EPA's concern about health effects from the chemical. The environmental group argues that the Toxic Substances Control Act required DuPont to send the results of the blood analysis to EPA promptly. DuPont says it is cooperating fully with the agency to provide any PFOA data of interest to the agency "and is committed to share details of all ongoing research on the compound."

Article:

This article has been sent to the following recipient:

0 /1 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.